Efgartigimod as a treatment for people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a plain language summary of publication of the ADHERE trial.
- DOI
- 10.1177/17562864251405202
- Published
- 2026
- Container
- Therapeutic advances in neurological disorders
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/17562864251405202,
title = {Efgartigimod as a treatment for people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a plain language summary of publication of the ADHERE trial.},
author = {Allen JA and Querol L and Suresh N and Remmerie A and Mole T and McCoy K and Butler L and van Hoorick B and Kuwabara S and van Doorn PA and Lewis RA},
year = {2026},
journal = {Therapeutic advances in neurological disorders},
doi = {10.1177/17562864251405202},
url = {https://doi.org/10.1177/17562864251405202}
}RIS
TY - JOUR TI - Efgartigimod as a treatment for people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a plain language summary of publication of the ADHERE trial. AU - Allen JA AU - Querol L AU - Suresh N AU - Remmerie A AU - Mole T AU - McCoy K AU - Butler L AU - van Hoorick B AU - Kuwabara S AU - van Doorn PA AU - Lewis RA PY - 2026 JO - Therapeutic advances in neurological disorders DO - 10.1177/17562864251405202 UR - https://doi.org/10.1177/17562864251405202 ER -
APA
JA, A., L, Q., N, S., A, R., T, M., K, M., L, B., B, V. H., S, K., PA, V. D., & RA, L. (2026). Efgartigimod as a treatment for people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a plain language summary of publication of the ADHERE trial.. Therapeutic advances in neurological disorders. https://doi.org/10.1177/17562864251405202
Source records
- pubmed · retrieved 2026-09-26T15:18:57.975Z